Latest Funding Arrangements News

Buru Energy revises its Rafael Gas Project development plan, prioritising drilling the Rafael B appraisal well in mid-2026 and delaying the Final Investment Decision by six months, while maintaining first production for late 2027.

Lefroy Exploration has secured a $2.5 million Profit Cash Advance Facility from BML Ventures, fully funding the Lucky Strike Gold Project through to profit-share distributions in early 2026 while avoiding shareholder dilution.

Lumos Diagnostics has voluntarily suspended its ASX trading pending a market announcement about strategic agreements, signaling potential shifts in its business trajectory.

Spacetalk Ltd has raised $3 million through convertible notes from its largest shareholder and converted $1 million of secured debt, positioning the company for international growth and new product development.

Kinterra Infrastructure has increased its takeover offer for New World Resources shares to A$0.063, with a potential rise to A$0.064 if it secures over 30% ownership. This move intensifies the takeover battle against rival CAML, promising quicker payments and stronger funding assurances.

Orion Minerals has raised approximately A$5.8 million through a share placement and loan conversions, while launching a Share Purchase Plan targeting an additional A$4 million to fund key copper projects.

Cobalt Blue Holdings has secured a three-year extension to its Major Project Status for the Broken Hill Cobalt Project, reinforcing its strategic importance to Australia’s critical minerals sector and enhancing development prospects.

Anax Metals has mutually withdrawn its arbitration against a cornerstone investor over exclusive marketing rights, keeping its convertible notes valid and avoiding immediate financial disruption.

Finder Energy has successfully raised $6 million through a placement led by major shareholder Longreach Capital, aiming to accelerate its Kuda Tasi and Jahal offshore oil development towards a Final Investment Decision.

Keybridge Capital has obtained a $9.3 million bridge funding facility from Active Asset Management, supported by an ASX waiver allowing the deal without prior shareholder approval. The funding aims to address urgent liquidity and solvency challenges while trading remains suspended.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

Butn Limited has locked in a $10 million corporate credit facility with Mighty Partners, providing non-dilutive capital to support its expanding receivables book and operational growth.